Desflurane versus propofol for general anesthesia maintenance in obese patients: A pilot meta-analysis

Inhalation anesthesia and total intravenous anesthesia (TIVA) regimens in patients with obesity: an updated systematic review and meta-analysis of randomized controlled trials

BACKGROUND

Obesity is a global epidemic, projected to affect 4 billion people by 2035. Anesthesia regimens, including volatile anesthetics and total intravenous anesthesia (TIVA), impact postoperative outcomes, particularly in obese patients who face increased risks of complications. Volatile anesthetics are often associated with higher rates of postoperative nausea and vomiting (PONV), while TIVA may improve recovery but can increase costs and present additional challenges. This systematic review and meta-analysis evaluate the effects of these anesthesia methods on perioperative outcomes, including hemodynamic stability, recovery, and PONV, in this high-risk population.

METHODS

Adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and registered in PROSPERO (CRD42024547776) studies were identified through PubMed, Web of Science, Scopus, China National Knowledge Infrastructure, CINDAHL, Cochrane, EMBASE, and Google Scholar. Two reviewers independently extracted data and assessed the risk of bias. A meta-analysis using a random-effects model was conducted.

RESULTS

Thirteen studies with 1072 participants were included. Inhalational anesthesia significantly increases PONV (RR, 2.09; 95% CI, 1.21-3.60; p = 0.01; I2 = 34%) and intraoperative heart rate (MD, 3.49; 95% CI, 0.01-6.97; p < 0.01; I2 = 67.6%) compared to TIVA. Other outcomes, including mean arterial pressure, duration of intensive care unit stay, recovery time, opioid use, and pain, showed no significant differences between TIVA and inhalational anesthesia in the present analysis.

CONCLUSION

TIVA appears to improve perioperative outcomes in obese patients by reducing PONV and intraoperative heart rate, highlighting its potential advantages in clinical practice. Further research is needed to address variability and establish evidence-based guidelines for anesthesia management in this high-risk population.

SYSTEMATIC REVIEW REGISTRATION NUMBER IN PROSPERO

CRD42024547776.

Doping Strategy of Monolayer MoS2 to Realize the Monitoring of Environmental Concentration of Desflurane: A First-Principles Study

Desflurane is a new volatile inhalation anesthetic that is widely used in medical operation. However, various diseases can be caused by chronic exposure to desflurane, which is also a greenhouse gas. Therefore, it is urgent to find a suitable method for monitoring desflurane. In this paper, the process of doping of Pd, Pt, and Ni on the MoS2 surface is simulated to determine the stability of the doping structure based on first-principles. The adsorption properties and sensing properties of Pd-MoS2, Pt-MoS2, and Ni-MoS2 on desflurane are explored by parameters including independent gradient model based on Hirshfeld partition (IGMH), electron localization function (ELF), and density of states (DOS), sensibility, and recovery time, subsequently. The doping results show that the three doping systems (Pd-MoS2, Pt-MoS2, and Ni-MoS2) are structurally stable, and the chemical bonds are formed with MoS2. The adsorption results show the best chemisorption between Pt-MoS2 and desflurane with the chemical bonds between them. The results of IGMH, ELF, and DOS also confirm it. The sensing characterization results show that the recovery time of Pt-MoS2 ranges between 85.27 and 0.027 s, and the sensitivity ranges from 99.26 to 25.69%, all of which can meet the requirements of the sensor. Considering the adsorption effect and sensing characteristics, Pt-MoS2 can be used as a gas-sensitive material for detecting the concentration of desflurane.

Enhanced recovery after bariatric surgery: an Italian consensus statement

Background

Enhanced recovery after bariatric surgery (ERABS) is an approach developed to improve outcomes in obese surgical patients. Unfortunately, it is not evenly implemented in Italy. The Italian Society for the Surgery of Obesity and Metabolic Diseases and the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care joined in drafting an official statement on ERABS.

Methods

To assess the effectiveness and safety of ERABS and to develop evidence-based recommendations with regard to pre-, intra-, and post-operative care for obese patients undergoing ERABS, a 13-member expert task force of surgeons and anesthesiologists from Italian certified IFSO center of excellence in bariatric surgery was established and a review of English-language papers conducted. Oxford 2011 Levels of Evidence and U.S. Preventive Services Task Force Grade Definitions were used to grade the level of evidence and the strength of recommendations, respectively. The supporting evidence and recommendations were reviewed and discussed by the entire group at meetings to achieve a final consensus.

Results

Compared to the conventional approach, ERABS reduces the length of hospital stay and does not heighten the risk of major post-operative complications, re-operations, and hospital re-admissions, nor does it increase the overall surgical costs. A total of 25 recommendations were proposed, covering pre-operative evaluation and care (7 items), intra-operative management (1 item, 11 sub-items), and post-operative care and discharge (6 items).

Conclusions

ERABS is an effective and safe approach. The recommendations allow the proper management of obese patients undergoing ERABS for a better outcome.